{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:13:34Z","timestamp":1787238814302,"version":"build-2736575974"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Interleukin-22 (IL-22) impacts the integrity of intestinal epithelia and has been associated with the development of colitis-associated cancer and inflammatory bowel diseases (IBD). Previous data suggest that IL-22 protects the mucosal barrier and promotes wound healing and barrier defect. We hypothesized, that IL-22 modulates cell polarity of intestinal epithelial cells (IECs) acting on tight junction assembly. The aim of the study was to investigate IL-22-dependent mechanisms in the reprogramming of intestinal epithelia.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    IECs were exposed to IL-22 at various concentrations. IECs in Matrigel\u00ae were grown to 3-dimensional cysts in the presence or absence of IL-22 and morphology and expression of polarity proteins were analyzed by confocal microscopy. Epithelial cell barrier (TER and sandwich assay) and TJ assembly analysis (calcium-switch assay) were performed. TJ and cell polarity protein expression were assessed by western blotting and confocal microscopy. Cell migration and invasion assays were performed. Induction of epithelial-mesenchymal transition (EMT) was assessed by RT-qPCR analysis and western blotting. Signaling pathway analyses were performed by phosphoblotting and functional assays after blocking STAT3 and ERK signaling pathways. Using the toxoplasma-model of terminal ileitis, IL-22-knock-out mice were compared to wild-type littermates, analyzed for barrier function using one-path-impedance-analysis and macromolecular flux (H3-mannitol, Ussing-chambers).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    IECs exhibited a barrier defect after IL-22 exposure. TJ protein distribution and expression were severely impaired. Delayed recovery in the calcium-switch assay was observed suggesting a defect in TJ assembly. Analyzing the 3D-cyst model, IL-22 induced multi-lumen and aberrant cysts, and altered the localization of cell polarity proteins. Cell migration and invasion was caused by IL-22 as well as induction of EMT. Interestingly, only inhibition of the MAPK pathway, rescued the TJal barrier defect, while blocking STAT3 was relevant for cell survival. In addition, ileal mucosa of IL-22 deficient mice was protected from the barrier defect seen in Toxoplasma gondii-induced ileitis in wild type mice shown by significantly higher Re values and correspondingly lower macromolecule fluxes.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    IL-22 impairs intestinal epithelial cell barrier by inducing EMT, causing defects in epithelial cell polarity and increasing cell motility and cell invasion. IL-22 modulates TJ protein expression and mediates tight junctional (TJal) barrier defects via ERK pathway.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2021.656047","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T02:23:28Z","timestamp":1618194208000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Reprogramming Intestinal Epithelial Cell Polarity by Interleukin-22"],"prefix":"10.3389","volume":"8","author":[{"given":"Deborah","family":"Delbue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Lebenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Cardoso-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Dony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Krug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan F.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhakankha","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melba","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Heldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus M.","family":"Heimesaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/ibd.22929","article-title":"Healing of intestinal inflammation by IL-22","volume":"18","author":"Mizoguchi","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cytogfr.2010.11.001","article-title":"IL-10 family of cytokines","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/ajg.2010.465","article-title":"Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients","volume":"106","author":"Fern\u00e1ndez","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2036.2009.04209.x","article-title":"Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients","volume":"31","author":"Veny","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.gene.6364144","article-title":"Is there an interaction between interleukin-10 and interleukin-22?","volume":"6","author":"Wolk","year":"2005","journal-title":"Genes Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"G827","DOI":"10.1152\/ajpgi.00513.2005","article-title":"IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration","volume":"290","author":"Brand","year":"2006","journal-title":"Am J Physiol\u2013Gastrointest Liver Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1084\/jem.20090900","article-title":"Interleukin (IL)-23 mediates toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17","volume":"206","author":"Mu\u00f1oz","year":"2009","journal-title":"J Exp Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7891","DOI":"10.4049\/jimmunol.181.11.7891","article-title":"Protective immunity to systemic infection with attenuated salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but Not IL-17","volume":"181","author":"Schulz","year":"2008","journal-title":"J Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.immuni.2010.12.009","article-title":"CD4+ lymphoid tissue-inducer cells promote innate immunity in the gut","volume":"34","author":"Sonnenberg","year":"2011","journal-title":"Immunity."},{"key":"B11","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","article-title":"Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease","volume":"29","author":"Zenewicz","year":"2008","journal-title":"Immunity."},{"key":"B12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"a027888","DOI":"10.1101\/cshperspect.a027888","article-title":"Mechanisms of cell polarity \u2013 controlled epithelial homeostasis and immunity in the intestine","volume":"9","author":"Klunder","year":"2017","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrd4065","article-title":"Cancer: IL-22: Linking inflammation and cancer","volume":"12","author":"Harrison","year":"2013","journal-title":"Nat Rev Drug Discov."},{"key":"B15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/gutjnl-2011-300123","article-title":"Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease","volume":"61","author":"Schumann","year":"2012","journal-title":"Gut."},{"key":"B16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.clim.2007.08.017","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction","volume":"126","author":"Li","year":"2008","journal-title":"Clin Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1084\/jem.20082683","article-title":"STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing","volume":"206","author":"Pickert","year":"2009","journal-title":"J Exp Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/MIB.0000000000000319","article-title":"IL-22-STAT3 pathway plays a key role in the maintenance of ileal homeostasis in mice lacking secreted mucus barrier","volume":"21","author":"Sovran","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/bjc.2014.336","article-title":"IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling","volume":"111","author":"Fukui","year":"2014","journal-title":"Br J Cancer."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.3390\/ijms20143468","article-title":"Interleukin (IL)-22 from IL-20 subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1\/2 pathway","volume":"20","author":"Moniruzzaman","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.bpj.2009.08.003","article-title":"Two-path impedance spectroscopy for measuring paracellular and transcellular epithelial resistance","volume":"97","author":"Krug","year":"2009","journal-title":"Biophys J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jconrel.2016.03.018","article-title":"A novel method for imaging sites of paracellular passage of macromolecules in epithelial sheets","volume":"229","author":"Richter","year":"2016","journal-title":"J Control Release."},{"key":"B23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1749-6632.2012.06565.x","article-title":"Defective tight junctions in refractory celiac disease","volume":"1258","author":"Schumann","year":"2012","journal-title":"Ann N Y Acad Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.chembiol.2006.11.001","article-title":"A new small-molecule stat3 inhibitor","volume":"13","author":"McMurray","year":"2006","journal-title":"Chem Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic: a small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1073\/pnas.0609757104","article-title":"Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity","volume":"104","author":"Siddiquee","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"45443","DOI":"10.1074\/jbc.M107527200","article-title":"Phosphotyrosyl peptides block stat3-mediated DNA binding activity, gene regulation, and cell transformation","volume":"276","author":"Turkson","year":"2001","journal-title":"J Biol Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1038\/sj.onc.1210031","article-title":"A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo","volume":"26","author":"Iwamaru","year":"2007","journal-title":"Oncogene."},{"key":"B29","doi-asserted-by":"publisher","first-page":"11291","DOI":"10.1158\/0008-5472.CAN-07-0593","article-title":"WP1066 disrupts janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells","volume":"67","author":"Ferrajoli","year":"2007","journal-title":"Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1016\/S0960-894X(98)00522-8","article-title":"MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products","volume":"8","author":"Duncia","year":"1998","journal-title":"Bioorganic Med Chem Lett."},{"key":"B31","doi-asserted-by":"publisher","first-page":"8785","DOI":"10.4049\/jimmunol.177.12.8785","article-title":"Gram-Negative bacteria aggravate murine small intestinal Th1-Type immunopathology following oral infection with toxoplasma gondii","volume":"177","author":"Heimesaat","year":"2006","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.immuni.2020.02.016","article-title":"Innate lymphoid cell-epithelial cell modules sustain intestinal homeostasis","volume":"52","author":"Diefenbach","year":"2020","journal-title":"Immunity."},{"key":"B33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.4049\/jimmunol.178.9.5973","article-title":"IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's Disease","volume":"178","author":"Wolk","year":"2007","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrm2523","article-title":"From cells to organs: building polarized tissue","volume":"9","author":"Bryant","year":"2008","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.chom.2017.05.009","article-title":"IL-22 upregulates epithelial claudin-2 to drive diarrhea and enteric pathogen clearance","volume":"21","author":"Tsai","year":"2017","journal-title":"Cell Host Microbe."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.4049\/jimmunol.1700152","article-title":"IL-22 increases permeability of intestinal epithelial tight junctions by enhancing claudin-2 expression","volume":"199","author":"Wang","year":"2017","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/gutjnl-2011-300498","article-title":"Interleukin-13 and transforming growth factor \u03b2 synergise in the pathogenesis of human intestinal fistulae","volume":"62","author":"Scharl","year":"2013","journal-title":"Gut."},{"key":"B41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial-mesenchymal transitions","volume":"7","author":"Thiery","year":"2006","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nature11535","article-title":"IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine","volume":"491","author":"Huber","year":"2012","journal-title":"Nature."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3390\/cells9102205","article-title":"Microbiota-dependent effects of IL-22","volume":"9","author":"Sabihi","year":"2020","journal-title":"Cells."},{"key":"B44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.gene.6363786","article-title":"A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta","volume":"2","author":"Gruenberg","year":"2001","journal-title":"Genes Immun."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.656047\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T02:23:34Z","timestamp":1618194214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.656047\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":44,"alternative-id":["10.3389\/fmed.2021.656047"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.656047","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]},"article-number":"656047"}}